Cargando…
Identification of Novel Bioactive Compound Derived from Rheum officinalis against Campylobacter jejuni NCTC11168
Gastric diseases are increasing with the infection of Campylobacter jejuni. Late stages of infection lead to peptic ulcer and gastric carcinoma. C. jejuni infects people within different stages of their life, especially childhood, causing severe diarrhea; it infects around two-thirds of the world po...
Autores principales: | Yosri, Mohammed, Amin, Basma H., Abed, Nermine N., Elithy, Amal S., Kareem, Sayed M., Sidkey, Nagwa M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349621/ https://www.ncbi.nlm.nih.gov/pubmed/32665768 http://dx.doi.org/10.1155/2020/3591276 |
Ejemplares similares
-
Domestication of Campylobacter jejuni NCTC 11168
por: Pascoe, Ben, et al.
Publicado: (2019) -
Transcriptomic analysis of Campylobacter jejuni NCTC 11168 in response to epinephrine and norepinephrine
por: Xu, Fuzhou, et al.
Publicado: (2015) -
Re-annotation and re-analysis of the Campylobacter jejuni NCTC11168 genome sequence
por: Gundogdu, Ozan, et al.
Publicado: (2007) -
Comparative Variation within the Genome of Campylobacter jejuni NCTC 11168 in Human and Murine Hosts
por: Thomas, Dallas K., et al.
Publicado: (2014) -
Motility related gene expression of Campylobacter jejuni NCTC 11168 derived from high viscous media
por: Su, Yulan, et al.
Publicado: (2023)